Marine Biotechnology Market Report 2025

The marine biotechnology market size has grown strongly in recent years. It will grow from $6.19 billion in 2024 to $6.64 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to environmental concerns, bioprospecting opportunities, pharmaceutical and nutraceutical demand, aquaculture innovation, bioenergy exploration.

The marine biotechnology market size is expected to see strong growth in the next few years. It will grow to $8.97 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to climate change mitigation, bioremediation applications, pharmaceutical drug discovery, food security solutions, bioinformatics integration. Major trends in the forecast period include aquatic biotechnology in personal care, synthetic biology in marine organisms, marine biotechnology collaborations, climate-resilient agriculture, marine biotechnology education and awareness.

The anticipated surge in demand for marine biotechnology in the energy sector is set to drive the growth of the marine biotechnology market. The energy sector comprises businesses involved in extracting, refining, or providing consumable fuels such as coal, oil, and gas. Marine biotechnology plays a crucial role in advancing more efficient and environmentally friendly energy systems, leveraging marine microbes for converting waste into electricity and microalgae for biofuel production. Its significance in the energy sector lies in harnessing unique features of marine organisms for applications such as biofuel generation, marine renewable energy, biodegradable products, and bioremediation. With the International Energy Agency (IEA) reporting a substantial 6% increase in global energy demand in January 2022, reaching over 1,500 terawatt-hours, the rising demand for marine biotechnology in the energy sector propels the marine biotechnology market.

The upward trend in biofuel production is expected to further bolster the growth of the marine biotechnology market. Biofuel, derived from organic materials undergoing biological processes, represents a renewable energy source. Marine biotechnology contributes to biofuel development, providing eco-friendly alternatives in response to the growing demand for renewable energy. As reported by the International Energy Agency in July 2023, biofuel demand surged to an unprecedented 4.3 exajoules (170,000 million liters) in 2022, with projections indicating a surpassing of 10 exajoules by 2030. The biofuels derived from waste, residues, and non-food energy crops are projected to fulfill over 40% of the total biofuel demand by 2030. This marks a significant increase from the approximately 9% share observed in 2021. Consequently, the rise in biofuel production becomes a driving force for the marine biotechnology market.

Product innovations are a significant trend gaining traction in the marine biotechnology market. Major companies in this sector are concentrating on developing new products to enhance their market position. For example, in September 2024, Hi-Q Marine Biotech International Ltd, a Taiwan-based biotechnology firm, introduced OliFuco RE, a product designed to manage sarcopenia and promote tissue regeneration, specifically targeting age-related muscle loss. OliFuco RE is a low molecular weight fucoidan powder sourced from brown seaweed, known for its bioactive properties. It facilitates muscle regeneration and notably improves muscle mass and strength in older adults. This scientifically validated formulation presents a promising solution for addressing sarcopenia and represents a potential breakthrough in nutraceuticals focused on muscle preservation and regeneration.

Major companies operating in the marine biotechnology market are developing marine bacteria-derived proteins to expand their customer bases, drive sales, and increase revenue. Marine bacteria-derived proteins are sourced from bacteria in marine environments. For instance, in December 2022, TransGen Biotech Co. Ltd., a China-based company, launched Uracil-DNA Glycosylase (Low Temperature), a recombinant protein from psychrophile marine bacteria. This enzyme efficiently hydrolyzes the N-glycosidic bond between uracil (dU) base and deoxyribose in DNA, eliminating aerosol contamination in PCR products containing dU.

In September 2024, Blue Future Holding, a Norway-based investment management company, acquired complete ownership of GreenFox Marine for an undisclosed sum. This acquisition bolsters Blue Future Holding's strategy to broaden its portfolio in the aquaculture sector and aligns with its commitment to investing in sustainable seafood solutions. GreenFox Marine, also based in Norway, specializes in developing advanced technologies for the aquaculture industry, particularly in automated sex sorting of salmon.

Major companies operating in the marine biotechnology market include Cyanotech Corporation, CP Kelco US Inc., PharmaMar S.A., Sea Run Holdings Inc., Nofima A.S., New England Biolabs Inc., Lonza Group Ltd., NovaMatrix, GlycoMar Ltd., SEPPIC Inc., Marinova Pty. Ltd., Prolume Ltd., Aker Biomarine Antarctic AS., Badische Anilin- und Sodafabrik, Royal DSM N.V, Tequesta Bioventures LLC, Marinomed Biotech AG, AstaReal Co. Ltd., Euglena Co.Ltd., Earthrise Nutritionals LLC, Bluebiotech International GmbH, Sams Corporation, Abbott Laboratories, Qingdao Codo International Ltd., Nutrex Hawai Inc., Kepley Biosystems Incorporated, Finless Foods Inc., Jellagen Pty Ltd, Ingenza Ltd, AMSilk GmbH, Centre for Process Innovation Limited, KnipBio Inc.

Europe was the largest region in the marine biotechnology market in 2024. The regions covered in the marine biotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the marine biotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Marine biotechnology is a scientific field that involves harnessing marine organisms, their genetic material, and related bioactive substances for diverse applications. This branch of science encompasses the study and manipulation of marine organisms, including plants, animals, and microorganisms, with the aim of developing products, processes, and technologies applicable in industries such as cosmetics, nutritional supplements, pharmaceuticals, and more.

The primary categories of marine biotechnological products include bioactive substances and biomaterials. Bioactive substances encompass a broad spectrum of biological, pharmacological, and nutraceutical activities, known for their beneficial effects on nutrition and health. Sources of these substances include corals and sponges, algae, marine viruses, marine fungi, and others. Various technologies are employed, such as the isolation and cultivation of microorganisms and culture-independent techniques. These technologies find applications in diverse fields, including aquaculture and food products, environmental and human health, and drug discovery. End-users of marine biotechnological products span industries such as medical and pharmaceutical, the food industry, the cosmetic industry, the chemical industry, and more.

The marine biotechnology market research report is one of a series of new reports that provides marine biotechnology market statistics, including marine biotechnology industry global market size, regional shares, competitors with a marine biotechnology market share, detailed marine biotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the marine biotechnology industry. This marine biotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The marine biotechnology market includes revenues earned by entities by providing services such as bioprospecting and bioactive compound discovery, genetic analysis and genomic studies, bioprocessing, fermentation, pharmaceutical discovery, and materials technology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.